Next Article in Journal
Bevacizumab for Glioblastoma—A Promising Drug or Not?
Next Article in Special Issue
1,25-Dihydroxyvitamin D3 (1,25(OH)2D3) Signaling Capacity and the Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer (NSCLC): Implications for Use of 1,25(OH)2D3 in NSCLC Treatment
Previous Article in Journal / Special Issue
The Protective Role of Vitamin D Signaling in Non-Melanoma Skin Cancer
Article Menu

Export Article

Open AccessDiscussion
Cancers 2013, 5(4), 1439-1455;

The Inverse Relationship between 25-Hydroxyvitamin D and Cancer Survival: Discussion of Causation

The Cancer Registry of Norway, Institute of Population-based Cancer Research, Oslo 0304, Norway
Departments of Cancer Biology, Urology, and Epidemiology and Prevention, Wake Forest University Baptist Medical Center, Winston-Salem, NC 27157, USA
Author to whom correspondence should be addressed.
Received: 22 September 2013 / Revised: 22 October 2013 / Accepted: 24 October 2013 / Published: 5 November 2013
(This article belongs to the Special Issue Vitamin D: Role in Cancer Causation, Progression and Therapy)
Full-Text   |   PDF [499 KB, uploaded 5 November 2013]   |  


Cancer mortality rates vary inversely with geographic latitude and solar ultraviolet-B doses. This relationship may be due to an inhibitory role of vitamin D on cancer development. The relationship between vitamin D and cancer appears to be stronger for studies of cancer mortality than incidence. Because cancer mortality reflects both cancer incidence and survival, the difference may be due to effects of vitamin D on cancer survival. Here we review analytic epidemiologic studies investigating the relation between vitamin D, measured by circulating levels of 25-hydroxyvitamin D (25-OHD), and cancer survival. A relationship between low 25-OHD levels and poor survival is shown by most of the reviewed studies. This relationship is likely to be causal when viewed in light of most criteria for assessing causality (temporality, strength, exposure-response, biological plausibility and consistency). A serum level of 25-OHD around 50 nmol/L appears to be a threshold level. Conversely, there are several mechanisms whereby cancer could lower serum levels of 25-OHD. The severity of disease at the time of diagnosis and time of serum sampling are key factors to clarify the temporal aspect of these relationships. Evidence that vitamin D supplementation could retard the disease process or prolong survival time would be key evidence, but is difficult to generate. However, recent clinical trial results in prostate cancer support a role for vitamin D in this regard. View Full-Text
Keywords: vitamin D; cancer survival; causality; reverse causality; temporality vitamin D; cancer survival; causality; reverse causality; temporality

Figure 1

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Robsahm, T.E.; Schwartz, G.G.; Tretli, S. The Inverse Relationship between 25-Hydroxyvitamin D and Cancer Survival: Discussion of Causation. Cancers 2013, 5, 1439-1455.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top